Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Califf

Showing results (311-320 of 567) with videos related to

Pageof 57
Sort By:
Circulation|July 1, 1994
Intravenous Fluosol in the treatment of acute myocardial infarction. Results of the Thrombolysis and Angioplasty in Myocardial Infarction 9 Trial. TAMI 9 Research GroupT C Wall, R M Califf, J Blankenship, et al.
Circulation|November 1, 1989
Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activatorS G Ellis, E J Topol, B S George, et al.
The American Journal of Cardiology|February 15, 1989
Prediction of early recurrent myocardial ischemia and coronary reocclusion after successful thrombolysis: a qualitative and quantitative angiographic studyT C Wall, D B Mark, R M Califf, et al.
The American Journal of Cardiology|October 8, 1999
Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III trial). Global Use of Strategies To Open occluded coronary arteriesJ M Miller, R Smalling, E M Ohman, et al.
Journal of the American College of Cardiology|March 27, 2001
Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromesM C Bahit, E J Topol, R M Califf, et al.
Journal of the American College of Cardiology|March 1, 1992
Accelerated plasminogen activator dose regimens for coronary thrombolysis. The TAMI-7 Study GroupT C Wall, R M Califf, B S George, et al.
Circulation|November 3, 1998
Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb InvestigatorsP W Armstrong, Y Fu, W C Chang, et al.
Journal of the American College of Cardiology|December 31, 1997
Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary ArteriesK W Mahaffey, C B Granger, C A Toth, et al.
The American Journal of Cardiology|February 19, 1998
Benefit of early sustained reperfusion in patients with prior myocardial infarction (the GUSTO-I trial). Global Utilization of Streptokinase and TPA for occluded arteriesD B Brieger, K H Mak, H D White, et al.
The American Journal of Cardiology|April 1, 1987
Prognostic effect of bundle branch block related to coronary artery bypass graftingA Chu, R M Califf, D B Pryor, et al.
Pageof 57

Showing results (311-320 of 567) with videos related to

Sort By:
Pageof 57
Circulation|July 1, 1994
Intravenous Fluosol in the treatment of acute myocardial infarction. Results of the Thrombolysis and Angioplasty in Myocardial Infarction 9 Trial. TAMI 9 Research GroupT C Wall, R M Califf, J Blankenship, et al.
Circulation|November 1, 1989
Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activatorS G Ellis, E J Topol, B S George, et al.
The American Journal of Cardiology|February 15, 1989
Prediction of early recurrent myocardial ischemia and coronary reocclusion after successful thrombolysis: a qualitative and quantitative angiographic studyT C Wall, D B Mark, R M Califf, et al.
The American Journal of Cardiology|October 8, 1999
Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III trial). Global Use of Strategies To Open occluded coronary arteriesJ M Miller, R Smalling, E M Ohman, et al.
Journal of the American College of Cardiology|March 27, 2001
Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromesM C Bahit, E J Topol, R M Califf, et al.
Journal of the American College of Cardiology|March 1, 1992
Accelerated plasminogen activator dose regimens for coronary thrombolysis. The TAMI-7 Study GroupT C Wall, R M Califf, B S George, et al.
Circulation|November 3, 1998
Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb InvestigatorsP W Armstrong, Y Fu, W C Chang, et al.
Journal of the American College of Cardiology|December 31, 1997
Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary ArteriesK W Mahaffey, C B Granger, C A Toth, et al.
The American Journal of Cardiology|February 19, 1998
Benefit of early sustained reperfusion in patients with prior myocardial infarction (the GUSTO-I trial). Global Utilization of Streptokinase and TPA for occluded arteriesD B Brieger, K H Mak, H D White, et al.
The American Journal of Cardiology|April 1, 1987
Prognostic effect of bundle branch block related to coronary artery bypass graftingA Chu, R M Califf, D B Pryor, et al.
Pageof 57